HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

4-Amino-1-((2R,3R,4S,5R)-3-amino-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidin-2(1H)-one

HCID 178790448
New noteNew reactionRequest quotes
Print preview

Completing data — refresh the page later to see the latest

Basic informationNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
869729-45-3
Standard SMILES
Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2N)c(=O)nc1N
InChIKey
QXOJXEANLQPLRK-JXOAFFINSA-N
Molecular formula
C10H16N4O4
Average molar mass
256.26 g/mol

Names & identifiers

Preferred name
4-Amino-1-((2R,3R,4S,5R)-3-amino-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidin-2(1H)-one
IUPAC
4-amino-1-[(2R,3R,4S,5R)-3-amino-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidin-2-one
English name
2'-Amino-2'-deoxy-5-methylcytidine
Molecular formula
C10H16N4O4
Molecular weight
256.26

Names & synonyms

869729-45-34-Amino-1-((2R,3R,4S,5R)-3-amino-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidin-2(1H)-one4-amino-1-[(2R,3R,4S,5R)-3-amino-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidin-2-oneorb1908745SCHEMBL1059100TNU0234FA1446492'-Amino-2'-deoxy-5-methylcytidine2’-Amino-2’-deoxy-5-methylcytidineCytidine, 2'-amino-2'-deoxy-5-methyl- (9CI)

Database identifiers

CAS
869729-45-3

Properties

Computed structural propertiesFilling in

XLogP
-2.3
Topological polar surface area
134 Ų
Hydrogen bond donors
4
Hydrogen bond acceptors
5
Rotatable bonds
2
Heavy atoms
18
Formal charge
0
Complexity
422

Physicochemical properties

Boiling point
525.5 · 525.5±60.0 °C(Predicted)
Density
1.78 · 1.78±0.1 g/cm3(Predicted)
pka
13.66 · 13.66±0.70(Predicted)

Chemistry & industry

Applications · 1 item

Uses2’-Amino-2’-deoxy-5-methylcytidine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes